Perception of risk regarding the use of medications and other exposures during pregnancy
✍ Scribed by Hedvig Nordeng; Eivind Ystrøm; Adrienne Einarson
- Publisher
- Springer
- Year
- 2009
- Tongue
- English
- Weight
- 152 KB
- Volume
- 66
- Category
- Article
- ISSN
- 0031-6970
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract ## BACKGROUND: Antihistamines are commonly used during pregnancy. There is little evidence that they have teratogenic effects, but there are knowledge gaps with respect to newer products, as well as the relationship between specific antihistamines and specific birth defects. ## METHOD
## Abstract ## BACKGROUND Treatment of asthma symptoms during pregnancy is crucial for maternal and fetal health. Short‐acting beta~2~‐agonists (SABA) are frequently used as rescue medications and long‐acting beta~2~‐agonists (LABA) are used as add‐on controller therapy for asthma during pregnancy